PAVmed
PAVM
5 hedge funds and large institutions have $481K invested in PAVmed in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
98% more capital invested
Capital invested by funds: $243K → $481K (+$238K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFW
Fusion Family Wealth
Woodbury,
New York
|
+$257K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$10.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FFW
1
Fusion Family Wealth
Woodbury,
New York
| $251K | +$257K | +124 | New |
|
|
LCS
2
Levin Capital Strategies
New York
| $112K | +$10.4K | +5 | +10% |
|
|
MSAM
3
Moloney Securities Asset Management
Manchester,
Missouri
| $66K | – | – | – |
|
4
Brown Advisory
Baltimore,
Maryland
| $45K | – | – | – |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $7K | +$8.28K | +4 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$5K | -2 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$2K | -1 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$1K | – | – |
|
PAVM Hedge Fund Activity: Q2 2017 in Review
5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2017, worth a combined $481K — up 98% from $243K a quarter earlier.
Fund positioning in PAVM was balanced in Q2 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Fusion Family Wealth, opening a new position worth an estimated $257K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5K sold.
- 5 institutional investors held PAVmed (PAVM) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $481K of PAVmed stock for Q2 2017, up 98% quarter-over-quarter.
- 2 funds opened new PAVmed positions in Q2 2017 and 2 closed out, a net change of 0 holders.
- The largest PAVmed buyer in Q2 2017 was Fusion Family Wealth, an estimated $257K added.
- The largest PAVmed seller in Q2 2017 was Tower Research Capital (TRC), an estimated $5K sold.
Based on aggregated 13F filings for Q2 2017.